
PharmaDrug (OTC: LMLLF) Receives Positive Results for DMT-Analogue Program to Treat Glaucoma
PharmaDrug receives encouraging potency data for candidate DMT-analogue molecules designed to treat primary open angle glaucoma Terasaki Institute advances PharmaDrug’s candidate DMT-analogue molecules into next phase of potency/kinetics study Terasaki Institute initiates fabrication of novel […]